Results 131 to 140 of about 6,745 (243)

606 IMpower110: Tertiary lymphoid structures (TLS) and clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with first-line atezolizumab or chemotherapy

open access: yesRegular and Young Investigator Award Abstracts, 2023
Robert Johnston   +19 more
openaire   +2 more sources

Dynamics of tertiary lymphoid structures and immune cross talk in early versus advanced colorectal cancer: potential implications for immunotherapy

open access: yesCancer Immunology, Immunotherapy
Background Irrespective of microsatellite status, immune checkpoint inhibitor therapy shows superior efficacy in early-stage colorectal cancer (CRC) compared to advanced cases.
Zixu Chen   +9 more
doaj   +1 more source

Tertiary lymphoid structures combined with biomarkers of inflammation are associated with the efficacy of neoadjuvant immunochemotherapy in resectable non‐small cell lung cancer: A retrospective study

open access: yesThoracic Cancer
Background Neoadjuvant immunochemotherapy can effectively downstage tumors and reduce the risk of postoperative recurrence and distant metastasis in patients with non‐small cell lung cancer (NSCLC).
Fuhao Xu   +6 more
doaj   +1 more source

BALTing the lung immune response [PDF]

open access: yes
Tertiary Lymphoid Structures (TLS) are aggregates of immune cells in non-lymphoid tissue. Located in several organs, they drive immune responses against infections, cancer, and autoimmune diseases.
Kirkby, Margarida Ferreira Pereira Bobela
core  

Cell-Targeted Inhibition of CaMK4 Suppresses Tertiary Lymphoid-like Structure Development in Lupus-Prone Mice. [PDF]

open access: yesInt J Mol Sci
Jamaly S   +7 more
europepmc   +1 more source

FOXP3<sup>+</sup> Cells in Tertiary Lymphoid Structures Have Adverse Impact on Overall Survival in Patients with Gastric Cancer. [PDF]

open access: yesMed Sci (Basel)
Paparella Karaman A   +6 more
europepmc   +1 more source

Initiation of Tertiary Lymphoid Structures for Cancer Immunotherapy. [PDF]

open access: yesResearch (Wash D C)
Zou JY, Li ZT, Wang ZC, Li H, Sun ZJ.
europepmc   +1 more source

IMpower110: tertiary lymphoid structures (TLS) and clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with first line atezolizumab ro chemotherapy

open access: yesJournal for ImmunoTherapy of Cancer, 2023
Srivastava, Minu   +18 more
openaire   +1 more source

Home - About - Disclaimer - Privacy